|
The Board of Hester Biosciences at its meeting held on 10 August 2018 as approved the following -
The Board of Directors declared 1st interim dividend of 20% that is Rs 2.00 per equity share on the face value of Rs 10 (ten) per share, for the financial year 2018-19.
Approved issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 100 crore, subject to approval of members.
Approved borrowings as a loan to the extent of US Dollar 10 million under External Commercial Borrowing (ECB) as per guidelines issued by Reserve Bank of India.
|